Navigation Links
WATCHMAN® Receives German Reimbursement Coverage
Date:10/1/2010

MINNEAPOLIS, Oct. 1 /PRNewswire/ -- Atritech announces German reimbursement coverage of the left atrial appendage closure procedure in 2011.  The 2011 G-DRG (German Diagnosis Related Group) Catalog recently published on the InEK website (www.g-drg.de) adds left atrial appendage closure procedure to an existing G-DRG code.

Atritech's WATCHMAN Left Atrial Appendage Closure Technology is a device alternative to long term warfarin therapy in patients with atrial fibrillation.  The WATCHMAN is the only LAA closure device that has been studied under a multi-center, prospective randomized clinical study (PROTECT AF). Initial results of the PROTECT AF clinical study were published in the Lancet in August, 2009.   The most recent data presented at the TCT meeting in Washington DC, continues to demonstrate a relative risk reduction of 30% for all stroke, cardiovascular death and systemic embolism compared to long term warfarin therapy.  

"The favorable reimbursement decision in Germany along with the recent National Institute for Health and Clinical Excellence (NICE) published guidelines on LAA Closure in the U.K., further validate the clinical and economic viability of LAA closure.  As our data continues to demonstrate a reduction in stroke risk and improved safety results, we expect favorable reimbursement decisions in other major markets looking to reduce the economic burden of stroke," says Jim Bullock, President & CEO Atritech.

About Atritech

Atritech is a privately held company based in Plymouth, Minnesota.  Major investors in Atritech include Split Rock Partners, Thomas, McNerney and Partners, Prism Venture Partners, Tullis-Dickerson, The Vector Group, Thoma Cressey Funds, The Rahn Group, SightLine Partners and Affinity Capital. For more information, visit www.atritech.net.


'/>"/>
SOURCE Atritech, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1

Related medicine technology :

1. Lingohocken Fire Company Receives PAD Donation After Recent Rescue at Fox Heath Farm
2. Abbott Receives FDA Market Clearance for Next-Generation Contact Lens Disinfecting Solution
3. Advanced Life Sciences Receives $1.5 Million From Exercise of Unit Warrants and Secures Financing Commitment
4. China Shenghuo Receives Notice from NYSE Amex LLC Regarding Listing Standards
5. Progenika Receives CE Mark for First DNA Chip to Detect Mutations in Lipoprotein Lipase (LPL) Gene
6. Hospira Receives TGA Approval for Nivestim™, Australias First Biosimilar Filgrastim
7. Hologics Selenia Dimensions (3-D) Digital Mammography Tomosynthesis System Receives Favorable Votes From FDA Advisory Panel
8. Microfluidic Systems (MFSI) Receives Award from Inc. Magazine
9. Netsmart Technologies InfoScriber™ e-Prescribing Service Receives Additional Surescripts® Certifications
10. Angel Medical Systems Receives CE Mark Approval for the AngelMed Guardian, an Implantable Device Designed to Provide Early Warning of a Heart Attack
11. Roche Receives FDA Approval for Second-Generation Hepatitis B Viral Load Test
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/24/2016)... , May 24, 2016 ... den Markt gebracht, die es Ärzten erlaubt, ihre ... zu behandeln: MDLinking kombiniert Live Streaming mit einer ... Umfeld zu kommunizieren. Mediziner in Europa, Afrika, Asien ... sich bereits für die Plattform registriert. ...
(Date:5/24/2016)... CHRISTCHURCH, New Zealand , May 24, 2016 ... scanning and informatics solutions for the healthcare sector, has been ... the New Zealand Hi-Tech Awards 2016. Dr ... a fantastic acknowledgement for our team.  It,s really good to ... the burden healthcare internationally. Our products are used in 35 ...
(Date:5/24/2016)... , May 24, 2016 ... de doble terapia del mundo, introduce catéteres para ... OrbusNeich, una compañía global especializada en ... vidas, ha expandido su cartera incluyendo productos para ... JADE™ y Scoreflex™ PTA son los dispositivos de ...
Breaking Medicine Technology:
(Date:5/24/2016)... ... May 24, 2016 , ... ... corporate identity and website at its “Transforming Outcomes” User Conference in Las Vegas ... reflect i2i’s ongoing success to set the market standard for meaningful population health ...
(Date:5/24/2016)... ... May 24, 2016 , ... ... of communication enabled solutions and managed services today announced a strategic partnership ... enterprise contact center market. , Altura, one of Avaya’s largest Platinum Business ...
(Date:5/24/2016)... Church, VA (PRWEB) , ... May 24, 2016 , ... ... 14-15, 2016 · Raleigh, NC, http://www.fdanews.com/humanerrordrugdevice , Human error is known to ... is unlikely that human error will ever be totally eliminated, many human performance problems ...
(Date:5/24/2016)... ... ... Regenerative Medicine is being transformed by ongoing research and clinical findings at ... results as have been achieved with Okyanos Cell Therapy are paving the ... patients worldwide. , As the Medical Advisory Chairman at Okyanos, Eric Duckers, MD, PhD, ...
(Date:5/24/2016)... ... May 24, 2016 , ... ... or injury that focuses on repairing the musculoskeletal and neuromuscular systems of the ... on functional restoration, NYDNRehab began providing treatments for physical therapy in New York, ...
Breaking Medicine News(10 mins):